PMID- 25281206 OWN - NLM STAT- MEDLINE DCOM- 20150722 LR - 20150831 IS - 1567-7257 (Electronic) IS - 1567-1348 (Linking) VI - 28 DP - 2014 Dec TI - Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. PG - 201-9 LID - S1567-1348(14)00366-9 [pii] LID - 10.1016/j.meegid.2014.09.032 [doi] AB - Human leukocyte antigen (HLA)-DQ genetic polymorphisms have been associated with chronic hepatitis B virus (HBV) outcomes. We aimed to determine impacts of HLA-DQ polymorphisms and their interactions with HBV mutations on the risks of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). rs2856718 (A>G) and rs9275319 (A>G) were genotyped in 1342 healthy controls, 327 HBV surface antigen (HBsAg) seroclearance subjects, 611 asymptomatic HBsAg carriers (ASCs), 1144 chronic hepatitis B (CHB) patients, 734 LC patients, and 1531 HCC patients using quantitative PCR. HBV mutations were detected by direct sequencing. Logistic regression analyses were utilized to assess the factors and/or multiplicative interactions significantly associated with liver diseases. rs9275319 variant genotypes were inversely associated with HBV persistence compared to HBV natural clearance subjects. rs2856718 variant genotypes significantly increased LC risk compared to ASCs plus CHB patients (GG vs. AA: odds ratio [OR], 1.52, 95% confidence interval [CI], 1.17-1.97 and AG+GG vs. AA: OR, 1.27; 95% CI, 1.04-1.54) and decreased HCC risk compared to HCC-free HBV-infected subjects (AG vs. AA: OR, 0.76; 95% CI, 0.65-0.89 and AG+GG vs. AA: OR, 0.78, 95% CI, 0.68-0.90). rs2856718 variant genotypes were significantly associated with an increased frequency of HBV A1726C mutation, a LC-risk, HCC-protective mutation, in genotype C. A rs9275319 variant genotype (GG) was significantly associated with an increased frequency of preS1 start codon mutation, an HCC-risk mutation, in genotype C. The interaction of rs2856718 AG+GG genotype with T1753V, a HCC-risk mutation, significantly reduced LC risk, with an OR of 0.26 (95% CI, 0.09-0.78); whereas the interaction of rs2856718 AG genotype with C1673T, a LC-risk mutation, significantly increased HCC risk, with an OR of 2.80 (95% CI, 1.02-7.66) in genotype C HBV-infected subjects. Conclusively, the HLA-DQ polymorphisms affect the risks of LC and HCC differently in chronic HBV-infected subjects, possibly via interacting with the HBV mutations. CI - Copyright (c) 2014 Elsevier B.V. All rights reserved. FAU - Ji, Xiaowei AU - Ji X AD - Department of Epidemiology, Second Military Medical University, 800 Xiangyin Road, Shanghai, China. FAU - Zhang, Qi AU - Zhang Q AD - Department of Epidemiology, Second Military Medical University, 800 Xiangyin Road, Shanghai, China. FAU - Li, Bin AU - Li B AD - Biliary Tract Surgery Department I, Eastern Hepatobiliary Surgery Hospital, Secondary Military Medical University, 225 Changhai Road, Shanghai, China. FAU - Du, Yan AU - Du Y AD - Department of Epidemiology, Second Military Medical University, 800 Xiangyin Road, Shanghai, China. FAU - Yin, Jianhua AU - Yin J AD - Department of Epidemiology, Second Military Medical University, 800 Xiangyin Road, Shanghai, China. FAU - Liu, Wenbin AU - Liu W AD - Department of Epidemiology, Second Military Medical University, 800 Xiangyin Road, Shanghai, China. FAU - Zhang, Hongwei AU - Zhang H AD - Department of Epidemiology, Second Military Medical University, 800 Xiangyin Road, Shanghai, China. FAU - Cao, Guangwen AU - Cao G AD - Department of Epidemiology, Second Military Medical University, 800 Xiangyin Road, Shanghai, China. Electronic address: gcao@smmu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20141002 PL - Netherlands TA - Infect Genet Evol JT - Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases JID - 101084138 RN - 0 (HLA-DQ Antigens) RN - 0 (Hepatitis B Surface Antigens) SB - IM MH - Adult MH - Carcinoma, Hepatocellular/*genetics/immunology/virology MH - Case-Control Studies MH - Female MH - Genetic Predisposition to Disease MH - Genotype MH - HLA-DQ Antigens/*genetics/immunology MH - Hepatitis B Surface Antigens/*genetics MH - Hepatitis B virus/*genetics/immunology MH - Hepatitis B, Chronic/*genetics/immunology/virology MH - Humans MH - Liver Cirrhosis/*genetics/immunology/virology MH - Liver Neoplasms/*genetics/immunology/virology MH - Male MH - Middle Aged MH - Mutation MH - Polymorphism, Single Nucleotide OTO - NOTNLM OT - HLA-DQ OT - Hepatitis B virus OT - Hepatocellular carcinoma OT - Liver cirrhosis OT - Mutations OT - Single nucleotide polymorphism EDAT- 2014/10/05 06:00 MHDA- 2015/07/23 06:00 CRDT- 2014/10/05 06:00 PHST- 2014/06/27 00:00 [received] PHST- 2014/09/21 00:00 [revised] PHST- 2014/09/25 00:00 [accepted] PHST- 2014/10/05 06:00 [entrez] PHST- 2014/10/05 06:00 [pubmed] PHST- 2015/07/23 06:00 [medline] AID - S1567-1348(14)00366-9 [pii] AID - 10.1016/j.meegid.2014.09.032 [doi] PST - ppublish SO - Infect Genet Evol. 2014 Dec;28:201-9. doi: 10.1016/j.meegid.2014.09.032. Epub 2014 Oct 2.